Presentation Information

[27-16-pm13S]Evaluation of genome edition using CRISPR-Cas12a adenovirus vectors reveals their efficient suppression of hepatitis B virus antigen production

○Eriko Yoshimitsu1, Eiko Sakai2, Tomohito Tsukamoto2, Chiharu Imamura1, Yukiko Ueyama(Toba)1,2,3,4, Koichi Watashi5, Fuminori Sakurai1,2, Kazuaki Chayama6, Hiroyuki Mizuguchi1,2,3,4,7,8 (1. Sch. of Pharm. Sci., Osaka Univ., 2. Grad. Sch. of Pharm. Sci., Osaka Univ., 3. NIBIOHN, 4. OTRI, Osaka Univ., 5. NIID, 6. HISINLSC, 7. MEI center, Osaka Univ., 8. CiDER, Osaka Univ.)